GLP-1 Receptor Agonists and Cancer—The Promise Is Real - Top-Institutions - MDSpire

GLP-1 Receptor Agonists and Cancer—The Promise Is Real

  • By

  • Richard C. Wender

  • May 11, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    TriNetX LLC
    TriNetX LLC

    Cambridge, MA

    Key Differentiators

    • Health Data Analytics

  • #2

    Karolinska Institutet
    Karolinska Institutet

    Stockholm, Sweden

    Key Differentiators

    • Medical Research
    • Endocrinology

  • #3

    NYU Grossman School of Medicine
    NYU Grossman School of Medicine

    New York, NY

    Key Differentiators

    • Medical Education
    • Endocrinology

  • #4

    Mayo Clinic Florida
    Mayo Clinic Florida

    Jacksonville, FL

    Key Differentiators

    • Clinical Practice
    • Endocrinology

  • #5

    University of Toronto
    University of Toronto

    Toronto, ON

    Key Differentiators

    • Medical Research
    • Endocrinology

Original Source(s)

GLP-1 Receptor Agonists and Cancer—The Promise Is Real

  • by Richard C. Wender

  • May 11, 2026

Related Content

Case Report: First description of an intracranial “NET” in ROHHAD syndrome; time to rename to the ROHHAD-NeCT syndrome?

Errors in Abstract and Table 1

  • May 15, 2026

Mesh-free prepectoral breast reconstruction: a safe and effective alternative